Met Life Investment Management, LLC Pulmonx Corp Transaction History

Met Life Investment Management, LLC

$14.7 Billion
Q1 2024

A detailed history of Met Life Investment Management, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 20,227 shares of LUNG stock, worth $127,834. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,227

Holding current value

$127,834

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$8.71 - $14.65 $176,177 - $296,325	20,227 New	20,227 $187,000
Q2 2023 Apr 29, 2024	BUY	$10.78 - $13.65 $218,047 - $276,098	20,227 New	20,227 $265,000
Q1 2023 May 09, 2024	BUY	$7.49 - $12.54 $151,500 - $253,646	20,227 New	20,227 $226 Million
Q3 2022 May 10, 2024	BUY	$15.35 - $23.99 $33,217 - $51,914	2,164 Added 11.98%	20,227 $336,000
Q3 2022 Mar 22, 2023	BUY	$15.35 - $23.99 $33,217 - $51,914	2,164 Added 11.98%	20,227 $336,000

Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $33,217 - $51,914	2,164 Added 11.98%	20,227 $337,000
Q2 2022 May 10, 2024	BUY	$14.0 - $27.95 $31,808 - $63,502	2,272 Added 14.39%	18,063 $265,000
Q2 2022 Jun 20, 2023	SELL	$14.0 - $27.95 $30,296 - $60,483	-2,164 Reduced 10.7%	18,063 $265,000
Q2 2022 Mar 22, 2023	BUY	$14.0 - $27.95 $31,808 - $63,502	2,272 Added 14.39%	18,063 $265,000
Q2 2022 Aug 11, 2022	BUY	$14.0 - $27.95 $31,808 - $63,502	2,272 Added 14.39%	18,063 $266,000
Q1 2022 May 10, 2024	BUY	$21.13 - $35.65 $333,663 - $562,949	15,791 New	15,791 $391,000
Q1 2022 Jun 20, 2023	SELL	$21.13 - $35.65 $93,732 - $158,143	-4,436 Reduced 21.93%	15,791 $391,000
Q1 2022 Mar 22, 2023	BUY	$21.13 - $35.65 $123,145 - $207,768	5,828 Added 58.5%	15,791 $391,000
Q1 2022 May 12, 2022	BUY	$21.13 - $35.65 $123,145 - $207,768	5,828 Added 58.5%	15,791 $392,000
Q4 2021 Jun 21, 2023	SELL	$29.72 - $45.1 $305,046 - $462,906	-10,264 Reduced 50.74%	9,963 $319,000
Q3 2021 Jun 21, 2023	SELL	$35.98 - $44.48 $369,298 - $456,542	-10,264 Reduced 50.74%	9,963 $358,000
Q2 2021 May 17, 2024	BUY	$37.61 - $48.0 $174,209 - $222,336	4,632 Added 86.89%	9,963 $439,000
Q2 2021 Jun 21, 2023	SELL	$37.61 - $48.0 $386,029 - $492,672	-10,264 Reduced 50.74%	9,963 $439,000
Q2 2021 Mar 22, 2023	BUY	$37.61 - $48.0 $174,209 - $222,336	4,632 Added 86.89%	9,963 $439,000
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $174,209 - $222,336	4,632 Added 86.89%	9,963 $440,000
Q1 2021 May 17, 2024	SELL	$44.0 - $67.54 $655,424 - $1.01 Million	-14,896 Reduced 73.64%	5,331 $243,000
Q1 2021 Jun 26, 2023	SELL	$44.0 - $67.54 $655,424 - $1.01 Million	-14,896 Reduced 73.64%	5,331 $244 Million
Q4 2020 May 24, 2024	SELL	$39.31 - $69.02 $585,561 - $1.03 Million	-14,896 Reduced 73.64%	5,331 $367,000
Q4 2020 Jun 22, 2023	SELL	$39.31 - $69.02 $585,561 - $1.03 Million	-14,896 Reduced 73.64%	5,331 $367,000
Q4 2020 Mar 22, 2023	SELL	$39.31 - $69.02 $585,561 - $1.03 Million	-14,896 Reduced 73.64%	5,331 $367,000
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $209,561 - $367,945	5,331 New	5,331 $368,000

Others Institutions Holding LUNG

# of Institutions

124

Shares Held

30.8M

Call Options Held

1.2K

Put Options Held

1.2K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Pulmonx Corp Transaction History